What Fueled The Previous Growth In The Vaccine Delivery Devices Market?
The vaccine delivery devices market has seen considerable growth due to a variety of factors.
• The vaccine delivery devices market has grown rapidly in recent years. It will grow from $6.39 billion in 2024 to $7.06 billion in 2025, at a CAGR of 10.5%.
This growth is attributed to large-scale vaccination campaigns, expanded immunization programs, the adoption of disposable syringes, smallpox eradication efforts, and global vaccine initiatives.
What Can Be Expected from the Vaccine Delivery Devices Market Size?
The vaccine delivery devices market is expected to maintain its strong growth trajectory in upcoming years.
• The vaccine delivery devices market is projected to grow rapidly, reaching $10.41 billion by 2029 with a CAGR of 10.2%.
Growth is attributed to the emphasis on immunization programs, expanded vaccine development, a growing pediatric and geriatric population, better cold chain management, and increased awareness of preventive healthcare. Trends include needle-free solutions, innovations in vaccine delivery technology, advancements in personalized medicine, and new self-administered vaccines.
What Are the Critical Driver Fuelling The Vaccine Delivery Devices Market's Growth?
The anticipated rise in infectious diseases is anticipated to boost the vaccine delivery devices market's growth. These diseases, caused by harmful microorganisms like bacteria, viruses, fungi, or parasites, can be transmitted from one person to another, or via animals, vectors, or contaminated objects. The spread of such diseases is attributed to factors such as increased global travel, rapid urbanization, shifting climate patterns, and population expansion. Vaccination delivery devices are integral in preventing the spread of these illnesses by effectively providing vaccines, building immunity, and minimizing transmission. For example, the World Health Organization (WHO), a Switzerland-based UN agency focused on global health, reported approximately 10.6 million cases of tuberculosis (TB) worldwide in 2022. The statistics included 5.8 million men, 3.5 million women, and 1.3 million children affected. Hence, the wide occurrence of infectious diseases is bolstering the expansion of the vaccine delivery devices market.
How Is The Vaccine Delivery Devices Market segmented?
The vaccine delivery devices market covered in this report is segmented –
1) By Type Of Device: Needle Free Injection Systems, Oral Delivery Systems, Nasal Delivery Systems, Jet Injectors, Microneedle Patches And Microinjectors
2) By Route Of Administration: Intradermal Vaccination, Intramuscular Vaccination, Subcutaneous Vaccination, Other Vaccinations
3) By End Users: Hospitals, Clinics, Other End Users
Subsegments:
1) By Needle Free Injection Systems: Spring-Based Injectors, Gas-Driven Injectors, Hybrid Injectors
2) By Oral Delivery Systems: Oral Tablets And Capsules, Oral Sprays, Oral Solutions
3) By Nasal Delivery Systems: Nasal Sprays, Nasal Drops, Nasal Powder Systems
4) By Jet Injectors: Pneumatic Jet Injectors, Electromechanical Jet Injectors
5) By Microneedle Patches And Microinjectors: Dissolvable Microneedles, Solid Microneedles, Microinjector Devices
Pre-Book The Vaccine Delivery Devices Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Trends Are Shaping The Vaccine Delivery Devices Market?
Leading corporations in the vaccine delivery devices market are focusing on product innovation to boost the effectiveness and safety of vaccine administration - a notable example being the development of prefillable syringes. These are drug administration devices that are specially engineered to store and deliver a set dosage of a medication, usually a vaccine in liquid form. In September 2022, an illustrative case involved Becton, Dickinson and Company (BD), a medical technology firm hailing from the US, which unveiled the BD Effivax Glass Prefillable Syringe. This state-of-the-art vaccine delivery device is designed to address the progressively changing needs of vaccine production. With an aim to augment efficiency and dependability in vaccine administration, this syringe employs advanced technology and stringent specifications. It ensures improved fill or finish and container dependability, helping to mitigate the possibilities of production line interruptions while boosting the manufacturing capacity.
Who Are the Key Players In The Vaccine Delivery Devices Market?
Major companies operating in the vaccine delivery devices market are:
• Pfizer Inc.
• Johnson & Johnson
• Merck & Co. Inc.
• Sanofi S.A.
• Novartis International AG
• AstraZeneca PLC
• 3M Company
• GlaxoSmithKline plc
• Moderna Inc.
• Becton Dickinson and Company (BD)
• Sinovac Biotech Co. Ltd.
• CSL Limited
• INOVIO Pharmaceuticals Inc.
• Terumo Corporation
• SCHOTT AG
• Serum Institute of India Pvt. Ltd.
• Bavarian Nordic A/S
• Dynavax Technologies Corporation
• CanSino Biologics Inc.
• Vaxxas Inc.
• PharmaJet Inc.
• Enesi Pharma Limited
• NanoPass Technologies Ltd.
• Gerresheimer AG
• Panacea Biotec Limited
What Is The Most Dominant Region In The Vaccine Delivery Devices Market?
North America was the largest region in the vaccine delivery devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the vaccine delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
